SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling

about

SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling

Item

http://www.wikidata.org/entity/Q58796673

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@en

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@nl

type

Item

label

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@en

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@nl

prefLabel

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@en

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@nl

P1476

SPARCL1 suppresses the prolife ...... ells via the MEK/ERK signaling

@en

P2093

Li Li

http://www.w3.org/2001/XMLSchema#string

Yan Ma

http://www.w3.org/2001/XMLSchema#string

Yuan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells

Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.

Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor.

Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.

Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the ERK pathway.

Expression of SPARC like protein 1 (SPARCL1), extracellular matrix-associated protein is down regulated in gastric adenocarcinoma.

SPARCL1 suppresses metastasis in prostate cancer.

Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.

PARP-1 may be involved in angiogenesis in epithelial ovarian cancer.

P304

3195-3201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2018.6575

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30233672

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

cancer research

P932

6143840

http://www.w3.org/2001/XMLSchema#string